| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.41 | 0.02 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |